R
0.024
0.00 (4.35%)
| Penutupan Terdahulu | 0.023 |
| Buka | 0.023 |
| Jumlah Dagangan | 828,490 |
| Purata Dagangan (3B) | 3,641,945 |
| Modal Pasaran | 56,015,520 |
| Harga / Jualan (P/S) | 20.33 |
| Harga / Buku (P/B) | 1.32 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -812.58% |
| EPS Cair (TTM) | -0.060 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -40.00% |
| Nisbah Semasa (MRQ) | 3.37 |
| Aliran Tunai Operasi (OCF TTM) | -33.42 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -16.48 M |
| Pulangan Atas Aset (ROA TTM) | -28.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -112.21% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (AU) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | RADIOPHARM FPO [RAD] | - | - |
AISkor Stockmoo
0.9
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.88 |
|
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 25.23% |
| % Dimiliki oleh Institusi | 15.91% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |